![](data:image/svg+xml;base64,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)
PRINTER'S NO. 1088
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
932
Session of
2017
INTRODUCED BY DiGIROLAMO, MURT, DRISCOLL, D. COSTA, PASHINSKI,
TAYLOR, D. MILLER, DOWLING, DAVIS, McNEILL, A. HARRIS, DeLUCA
AND CALTAGIRONE, MARCH 23, 2017
REFERRED TO COMMITTEE ON HUMAN SERVICES, MARCH 23, 2017
AN ACT
Providing for licensure of buprenorphine office-based
prescribers; limiting the use of buprenorphine; and
establishing penalties.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Short title.
This act shall be known and may be cited as the Buprenorphine
Medically Assisted Treatment Act.
Section 2. Definitions.
The following words and phrases when used in this act shall
have the meanings given to them in this section unless the
context clearly indicates otherwise:
"Buprenorphine." A material, compound, mixture of
preparation containing buprenorphine or its salts used as
medically assisted treatment for opioid addiction.
"Buprenorphine office-based prescriber." A person that is
assigned a waiver from the Drug Enforcement Administration,
including a special identification number, commonly referred to
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18